Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 Thermothelomyces Heterothallica Protein Expression PlatformArticle Published on 2022-04-012023-07-09 Journal: Toxicologic pathology [Category] COVID19(2023년), [키워드] C1 COVID-19 Rabbits RBD Safety SARS-CoV-2 Thermothelomyces heterothallica Toxicity Vaccine [DOI] 10.1177/01926233221090518 PMC 바로가기